Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piemontino, U
Right arrow Articles by Di Minno, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piemontino, U
Right arrow Articles by Di Minno, G
Haematologica, Vol 79, Issue 4, 387-392
Copyright © 1994 by Ferrata Storti Foundation

Journal Article

Hemostatic and metabolic abnormalities in diabetes mellitus. The search for a link

U Piemontino, A Ceriello, and G Di Minno

Clinica Medica, Universita degli Studi di Napoli, Italy.

BACKGROUND. As many as 80% of diabetic patients die from major thrombotic complications of atherosclerosis, stroke and myocardial infarction. Plasma and cellular components of the hemostatic system are often abnormal in diabetic patients, and some of these abnormalities may play a role in the high risk of thrombosis in these patients. MATERIALS AND METHODS. Clinical studies imply that certain hemostatic abnormalities of diabetic patients are related, to some extent, to poor metabolic control. Thus, a critical review of the data available in the specialized literature has been carried out. RESULTS. Although suggestive, the link between hemostatic and metabolic abnormalities in diabetes mellitus is only circumstantial. Little is known about similarities and differences between type I and type II diabetes mellitus with respect to hemostatic parameters. Likewise, current understanding of the effects on the hemostatic system of the combination of glucose and lipid abnormalities often coexisting in diabetic patients is rather limited. CONCLUSIONS. Ad hoc studies are mandatory to clarify unsolved issues in this field and define the extent to which good metabolic control is crucial to preventing the risk of thrombosis in diabetes mellitus.


This article has been cited by other articles:


Home page
 Eur Heart JHome page
E. Bonnefoy, P. G. Steg, S. Chabaud, P.-Y. Dubien, F. Lapostolle, F. Boudet, J.-M. Lacroute, F. Dissait, G. Vanzetto, A. Leizorowicz, et al.
Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial
Eur. Heart J., September 1, 2005; 26(17): 1712 - 1718.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
H. Tikiz, U. Tezcan, M. Ileri, Y. Balbay, R. Atak, and E. Kutuk
Diabetes Mellitus Adversely Affects the Outcomes of Thrombolytic Therapy in Patients with Acute Myocardial Infarction
Angiology, July 1, 2003; 54(4): 449 - 456.
[Abstract] [PDF]

Home page
 HeartHome page
L F Hsu, K H Mak, K W Lau, L L Sim, C Chan, T H Koh, S C Chuah, R Kam, Z P Ding, W S Teo, et al.
Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis
Heart, September 1, 2002; 88(3): 260 - 265.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
K.-H. Mak and E. J. Topol
Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus
J. Am. Coll. Cardiol., March 1, 2000; 35(3): 563 - 568.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 1994 by the Ferrata Storti Foundation.